First-line Combination Treatment Based on Anlotinib
NCT03628521
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Advanced Stage
Interventions
DRUG:
Anlotinib，Erlotinib，IBI308，Pemetrexed，gemcitabine，carboplatin
Sponsor
Shanghai Chest Hospital